PPT-BELATACEPT

Author : luanne-stotts | Published Date : 2018-01-20

DB06681 C 3508 H 5440 N 922 O 1096 S 32 923 kDa with glycosylation CATEGORIES Antirheumatic Agents Immunosuppressive Agents DESCRIPTION Belatacept is a soluble

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "BELATACEPT" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

BELATACEPT: Transcript

DB06681 C 3508 H 5440 N 922 O 1096 S 32 923 kDa with glycosylation CATEGORIES Antirheumatic Agents Immunosuppressive Agents DESCRIPTION Belatacept is a soluble fusion protein which links the extracellular domain of human cytotoxic Tlymphocyteassociated antigen 4 CTLA4 to the modified Fc hinge CH2 and CH3 domains portion of human immunoglobulin G1 IgG1 Structurally . Immunosuppressive Agents . RILONACEPT . . DESCRIPTION. INDICATION. Rilonacept. is a . dimeric. fusion protein consisting of portions of IL-1R and the IL-1R accessory protein linked to the .

Download Document

Here is the link to download the presentation.
"BELATACEPT"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.